1st NCI annual meeting on Clinical Proteomic Technologies for Cancer.
The National Cancer Institute of the US National Institutes of Health established a Clinical Proteomic Technologies Initiative for Cancer (CPTI) in 2006. The first annual meeting organized by the CPTI program provided up-to-date information on the research activities and achievements at its first anniversary of this program. Presentations were made by leaders from the five centers nationwide of the Clinical Proteomic Technology Assessment for Cancer (CPTAC), and other principal investigators funded by the CPTI.
Tao
Feng
F
Pressure BioSciences, Inc., R&D, 321 Manley St, W. Bridgewater, MA 02379, USA. ftao@pressurebiosciences.com
D000046:Academic Medical Centers / Q000458:organization & administration; D014408:Biomarkers, Tumor / Q000032:analysis* / Q000097:blood; D001798:Blood Proteins / Q000032:analysis; D002173:Cancer Care Facilities / Q000458:organization & administration; D005380:Financing, Government; D006801:Humans; D007202:Indicators and Reagents / Q000592:standards; D013058:Mass Spectrometry; D008495:Medical Oncology / Q000379:methods*; D054547:National Cancer Institute (U.S.) / Q000191:economics / Q000458:organization & administration*; D009363:Neoplasm Proteins / Q000032:analysis* / Q000097:blood; D009369:Neoplasms / Q000097:blood / Q000737:chemistry* / Q000175:diagnosis; D040901:Proteomics / Q000379:methods / Q000458:organization & administration* / Q000592:standards; D012109:Research Support as Topic; D014481:United States; D014495:Universities / Q000458:organization & administration
D014408:Biomarkers, Tumor; D001798:Blood Proteins; D007202:Indicators and Reagents; D009363:Neoplasm Proteins